67, P = .001) and TP (r = .59, P = .021), but not SN-38 in vitro serum UA. Seven patients required over 3000 IU of AT-III concentrate to obtain an increase in the serum AT-III activity to over 70%. The UA level in this group was significantly higher than that in the remaining patients. Conclusion: The serum AT-III activity was correlated with the serum albumin level before the start of treatment. Therefore, measurement of the serum albumin level before and during treatment is helpful.”
“The use of compatibilizers as interfacial agents in composites can offer a convenient way to improve the mechanical properties of immiscible polymer blends.

The aim of this article is to illustrate the compatibilization effect of polyethylene-graft-maleic anhydride (PEgMA) in blends of low-density polyethylene (LDPE) and n-dodecyl-benzene sulfonate doped polyaniline (PANIDBSA) prepared by extrusion. Films with different compositions of the

coupling agent were evaluated with optical spectroscopy and thermomechanical, electrical, mechanical, and morphological techniques. selleck chemical The incorporation of PEgMA into the LDPE/PANIDBSA composites resulted in an improvement of their electrical conductivity and changes in the mechanical and morphological properties of the films. When 5 wt % of the coupling agent was added to a 30 wt % of the polyaniline-containing film, the conductivity increased by more than three orders of magnitude, and the ductility also improved qualitatively. The morphology analysis also indicated that the addition of PEgMA produced a strengthening of the filler-matrix interfacial region. (C) 2010 Wiley Periodicals, Inc. J Appl Polym Sci 119: 2895-2901, 2011″
“Legionnaire disease is a rare cause of community-acquired pneumonia SRT2104 in vivo in children and an exceedingly rare diagnosis in infants and neonates, with only few reported cases. We describe a case of fatal Legionnaire disease diagnosed by culture and polymerase chain reaction method from sputum and lung biopsy specimens, and emphasize the importance of

considering this rare entity in cases of severe neonatal pneumonia.”
“Objective: To explore the clinical values of laser ablation as a new treatment for portal vein tumor thrombus (PVTT). Methods: A total of 43 male patients with primary liver carcinoma (PLC)-associated PVTT were randomized into a laser ablation group and a radiotherapy group. The laser ablation group of 21 cases received direct percutaneous laser ablation under ultrasonographic guide, followed by direct injection into the portal vein with chemotherapy drugs including mitomycin C (MMC) and fluorouracil (5-Fu). The radiotherapy group of 22 cases was treated with X-ray in three-dimensional conformal radiotherapy (3D CRT) once a day for a total of 10 days course. After the treatment, all patients were followed for postoperative adverse reactions, changes of tumor thrombus, and survival time.